We transform
real world data
into clinical insight


Approach

Evidence-driven methodology for real-world impact

We work across diverse real world data sources — claims, electronic health records, registries, and patient-reported outcomes — to generate actionable clinical evidence that accelerates drug development and informs diagnostic strategy.

Our analytical frameworks are designed to meet the evidentiary standards required by regulators, payers, and clinical decision-makers alike.

Structured clinical concepts extracted from an unstructured clinical note
Free-text clinical notes carry most of what matters clinically, and almost none of it in a form that can be counted. We resolve it into defined fields, and we measure how often we get each one right.

Services
01

Real World Data Analysis

We harness the breadth of real world data — from claims and EHR to registries and wearables — to characterize disease burden, treatment patterns, and patient outcomes across diverse populations.

02

Clinical Development Insights

We support every stage of clinical development with evidence-based insights — from protocol design and endpoint selection to post-market surveillance and lifecycle management of human therapeutics.

03

Drug & Diagnostics Research

From comparative effectiveness to diagnostic accuracy studies, we deliver research that positions novel therapeutics and diagnostics within the evolving landscape of precision medicine and value-based care.

04

Clinical Concept Extraction

Most of the clinical detail that determines whether a study can be done at all sits in free-text notes. We use large language models to extract structured clinical concepts from that text against a defined schema, and we validate the output against a human-annotated reference standard — reporting sensitivity and specificity field by field, the way a diagnostic test is evaluated. Extraction that has not been measured this way is not evidence.


About

Scientific rigor. Clinical relevance.
Measurable outcomes.

Depth of Experience

We draw on decades of experience working with longitudinal real-world datasets spanning millions of patients — claims, registries, genomics, and digital health sources.

Analytical Precision

Telos applies advanced biostatistics, epidemiological methods, and machine learning to surface signal from complex, heterogeneous datasets, working with named subject-matter collaborators as each engagement requires.

Regulatory Alignment

Studies are designed to the evidentiary standards FDA, EMA, and HTA bodies apply — so that what the analysis produces can stand up in a submission, a label expansion, or a coverage decision.

Founder

Mark L. Watson, M.D., Ph.D.

Physician-scientist with two decades in drug and diagnostic development, spanning regulatory science, clinical trial design, and analytics at scale. Previously chief operating officer of a national EMR analytics company.

Telos Analytics LLC is a South Carolina limited liability company based in Greenville, South Carolina.


Contact

Let's build the evidence
together.

Whether you're a biopharma sponsor, diagnostic company, or research institution — we'd welcome a conversation about your data challenges.

Or email us directly at info@telosanalytics.net

Telos Analytics LLC
3620 Pelham Road
Greenville, SC 29615

Follow Telos Analytics on LinkedIn →